PSYD_0105: KCL

<i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Cross-sectional study including </b><b>participants with</b><b> psychosis spectrum disorder </b><b>with persistent psychotic experiences (PEs) with a need for care (</b><b>clinical group</b><b>, non-need-for-care participants with PEs (non-clinical group</b><b>), and no-PE healthy control participants</b><b>.</b><b>Contributors and PI’s: </b>Veena KumariInstitute of Psychiatry, Psychology and Neuroscience (IOPPN), King’s College London, U.K.<b>Key Details &amp; Variables</b><b>Data Type</b>Feature Data<b>Age Range</b>23-70<b>Number of Participants</b>47<b>Diagnostic Criteria</b>SCZ, HSZT<b>Number of Clinical Subjects</b>31<b>Number of Clinical Subjects (follow-up)</b>N/A<b>Number of Control Subjects</b>16<b>Number of Control Subjects (follow-up)</b>N/A<b>Demographic Information</b>Age, Sex, Ethnicity, Education, Handedness<b>Clinical Measures</b>SAPS, SANS, O-LIFE<b>Cognitive Measures</b>WASI Estimated FSIQ<b>Clinical Functioning Measures</b>N/A<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>Name<b>Antipsychotic Dose Recorded</b>Yes<b>CPZ Equivalents Recorded</b>No<b>Other Medication Variables Recorded</b>Yes<b>Recreational Drug/ Alcohol Use</b>Yes<i>Note: the above table features key details and variables and is not an exhaustive list.</i>